Browsing Tag
TLX101-Px
2 posts
Telix Pharmaceuticals (TLX) gains European review momentum for TLX101-Px brain cancer imaging candidate
Telix has a glioma imaging gap to fill. Europe’s TLX101-Px review could test whether radiopharma can move beyond prostate cancer.
Could Pixclara become the missing imaging tool in U.S. glioma care after FDA NDA acceptance?
Could Pixclara transform U.S. glioma imaging after FDA NDA acceptance? Explore what Telix Pharmaceuticals Limited’s September catalyst could change next.